NimbleGen Systems, a Madison biotech company with a new way of making gene chips, has hired a chief financial officer with some Wall Street experience and a Harvard MBA.
The move is viewed as a prelude to filing an application – possibly by the end of the year – to trade NimbleGen’s shares on the stock market. Nimblegen is a UW-Madison spinoff company.